1. Can l-carnitine reduce post-COVID-19 fatigue?
- Author
-
Roya Vaziri-harami and Parisa Delkash
- Subjects
Coronavirus ,CFS, Chronic fatigue syndrome ,COVID-19 ,RAS, renin-angiotensin system ,Surgery ,Review ,General Medicine ,ACE2, angiotensin-converting enzyme 2 ,l-carnitine ,Fatigue ,PVN, paraventricular nucleus ,IL, interleukin - Abstract
A significant number of patients infected with the new coronavirus suffer from chronic fatigue syndrome after COVID-19, and their symptoms may persist for months after the infection. Nevertheless, no particular treatment for post-disease fatigue has been found. At the same time, many clinical trials have shown the effectiveness of l-carnitine in relieving fatigue caused by the treatment of diseases such as cancer, MS, and many other diseases. Therefore, it can be considered as a potential option to eliminate the effects of fatigue caused by COVID-19, and its consumption is recommended in future clinical trials to evaluate its effectiveness and safety.
- Published
- 2022
- Full Text
- View/download PDF